Hello everyone. Thank you so much for coming. I'm truly honored to be here.Ambitious. I have heard that word many times. Usually right before I'm about to do something unusual, something unexpected, a little outside the box.And every time I hear it, it lands differently. I still remember the first time it really confused me. I was at a family gathering with my cousins when I told them that I wanted to build my career in healthcare that I wanted to become a doctor and right away they said oh you want to beco ...

Lucas. His soul chose this body, chose us as parents. For the world to care about rare diseases, people's hearts need to be changed.You know, we can't just have money be thrown into the problem. 831 is blindfolded and can no longer see what's going on. Beast games application.Mr. . beast, I don't have a job right now. Like I think I can apply $10 million.It's all a miracle. But it's also tragic to think that I have to go in the largest game show ever for people to know about my son. Keep going.Good job. Gre ...

Clinical Trial Outcome - The pharmaceutical company's ceralasertib combination failed to meet the primary endpoint in a late-stage clinical trial for advanced lung cancer [1]

Clinical Trial Overview - A clinical trial explored a "one-size-fits-all" vaccine's potential in preventing pancreatic cancer recurrence [1] - The trial included approximately 20 pancreatic cancer patients and 5 colorectal cancer patients, all having undergone standard treatments like chemotherapy and surgery [2] - Patients received six priming doses of an experimental vaccine [2] Vaccine Efficacy and Immune Response - The trial aimed to determine if the cancer vaccine could prevent recurrence and extend recurrence-free survival in patients who had standard treatments [3] - About 85% of individuals who received the cancer vaccine mounted the expected immune response [3] - Approximately two-thirds of the participants exhibited a robust immune response that was still detectable months after therapy, extending their cancer-free survival to about 29 months [3] Vaccine Mechanism and Significance - The cancer vaccine primes the immune system to recognize specific mutations present in cancer cells [5] - It introduces a snippet of a genetic mutation, triggering the immune system to identify and eliminate cells with that mutation [5] - This approach exploits the immune system's ability to kill cancer cells [5] Development Stage and Future Prospects - The trial was an early phase one trial with 25 participants [6] - Further success in phase two and phase three trials is necessary before potential FDA approval [6] - The vaccine targets a genetic mutation not specific to pancreatic or colorectal cancer, making it potentially usable in any cancer with that mutation [8][9]

Vaccine Recommendations & Insurance Coverage - Removing recommendations may impact patient choice, especially for vulnerable populations who rely on no-cost vaccines linked to CDC and ASIP recommendations [1][3] - Insurance companies have individual policies, some may not cover important treatments [2] - Various programs (private insurers, employer-sponsored plans, Medicare Part D, Medicaid, Vaccines for Children) link no-cost vaccines to CDC/ASIP recommendations [3] FDA's Role & Vaccine Safety - FDA's role is to assess the safety and effectiveness of submitted applications [4] - Concerns raised about potential loss of trust in the FDA due to policies perceived as "rubber stamping" vaccines without sufficient evidence, particularly for young, healthy individuals [5] - Industry emphasizes the need for strong evidence when recommending interventions, especially for new viruses and vaccines [5] - Clinical trial results in children were mixed four years ago [6]